← All trials
NCT04849013
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 11, 2021
- Primary completion
- Jan 1, 2023
- Completion date
- Jan 1, 2023
- First posted
- Apr 19, 2021
- Last posted
- Aug 18, 2021
- Enrollment
- 16
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of BaselLead sponsor
- University of BaselOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.